Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family
about
ERK8 is a negative regulator of O-GalNAc glycosylation and cell migrationThe heterotaxy gene GALNT11 glycosylates Notch to orchestrate cilia type and laterality.Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)Mucin-Type O-Glycosylation in Gastric CarcinogenesisGlycomic Approaches for the Discovery of Targets in Gastrointestinal CancerGlycosylated Notch and CancerMucin-type O-glycosylation during developmentGalnt1 is required for normal heart valve development and cardiac functionStrong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinomaGlycomimetics Targeting Glycosyltransferases: Synthetic, Computational and Structural Studies of Less-Polar ConjugatesMultiple Hepatic Regulatory Variants at the GALNT2 GWAS Locus Associated with High-Density Lipoprotein CholesterolMicroarray Analysis of the Major Depressive Disorder mRNA Profile DataArabidopsis ROCK1 transports UDP-GlcNAc/UDP-GalNAc and regulates ER protein quality control and cytokinin activityEndoplasmic reticulum: Where nucleotide sugar transport meets cytokinin control mechanisms.Characterization and expression analysis of Galnts in developing Strongylocentrotus purpuratus embryos.Inhibitor of ppGalNAc-T3-mediated O-glycosylation blocks cancer cell invasiveness and lowers FGF23 levels.Glycobiology of neuroblastoma: impact on tumor behavior, prognosis, and therapeutic strategies.O-glycosylation regulates polarized secretion by modulating Tango1 stability.Low density lipoprotein receptor class A repeats are O-glycosylated in linker regionsBiochemical characterization of functional domains of the chaperone CosmcMembrane protein profiling of human colon reveals distinct regional differencesCharacterization of the viral O-glycopeptidome: a novel tool of relevance for vaccine design and serodiagnosisOverexpression of Galnt3 in chondrocytes resulted in dwarfism due to the increase of mucin-type O-glycans and reduction of glycosaminoglycansGlycophenotypic alterations induced by Pteridium aquilinum in mice gastric mucosa: synergistic effect with Helicobacter pylori infectionImmature truncated O-glycophenotype of cancer directly induces oncogenic featuresThe gastrointestinal mucus system in health and diseaseDevelopment of isoform-specific sensors of polypeptide GalNAc-transferase activity.Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysisThe GalNAc-type O-Glycoproteome of CHO cells characterized by the SimpleCell strategySuppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3 glycans in human colon cancer cellsMultiple enzyme approach for the characterization of glycan modifications on the C-terminus of the intestinal MUC2mucin.The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system.Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution.Expression and characterization of the first snail-derived UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase.Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.O-linked glycosylation of the mucin domain of the herpes simplex virus type 1-specific glycoprotein gC-1 is temporally regulated in a seed-and-spread mannerA glycogene mutation map for discovery of diseases of glycosylation.Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen.A strategy for O-glycoproteomics of enveloped viruses--the O-glycoproteome of herpes simplex virus type 1The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors.
P2860
Q21128777-55534E44-9615-44E9-B8C6-B4950D6C85B4Q24339579-1681A4CF-991F-4085-8DE1-CA087B00776AQ26739942-B69222C4-B948-44BC-B964-CA460BCA5099Q26740541-59AFD1A5-73CC-4D2C-9A1C-04E526B36EDFQ26750872-8B4788EB-3A5F-4739-8109-A9161E153683Q26765743-589987EE-E66A-45FF-A508-B4A7E136DA13Q26849608-B1446137-7534-4FDF-9951-9D6B7B115321Q27318706-02B33FA8-CF06-425B-9664-F73651F1408BQ27339711-B920F13F-EBFB-4CEA-B929-F6BA6D2A34ADQ27704561-1EB7D686-ED77-4119-975B-8C9450A6A6D8Q30277960-9CB3E847-688D-45DA-AB27-4AB546357099Q30982409-26C92C1F-1166-409C-A42E-1D9FA75BA6B8Q33359751-74D81E80-DAEE-447D-869F-7A4A31A667E8Q33361622-4E325717-AC85-41EE-B511-100C1F346601Q33610666-47F6D47D-B60C-48C8-B10B-02917113B2F6Q33611054-C0EA4D5D-01E7-49CB-B0F7-A1B39E85C01EQ33659849-F36284F1-903D-4ACF-9C35-A59D40A9813CQ33665521-3C4CAF8D-CFB7-4E1B-90CA-8E89A0C10EA2Q33792840-B56B1655-BC88-43B5-A789-7391F1929F2FQ33860182-9ACFFA43-FE46-4D69-A549-AE2FFF9D4A64Q34157647-2BBF79AA-83F7-4B04-AD23-418FA47EC1B5Q34227510-EF12E7EC-E736-48DE-BE7D-AF64D0400407Q34249099-74557A0B-6A61-480E-B4E2-D6CB7503642BQ34311876-6959A392-0BDD-41BA-A919-9DE1DD07FD9AQ34314283-16FD4D55-17FF-4D33-A818-7972CFE39735Q34332180-240D5918-C25F-494F-A018-2FA8592A8630Q34431015-D36A6AFA-4F36-4951-AB3B-2CEC1A7A5ED8Q34579581-33012151-ED3F-4BCD-B927-9277F179CA05Q34634855-FFF922A7-8593-4B1C-B3B7-ADFE62D7434CQ34639786-DAA2B8C9-E660-4845-AD0A-F611F3F643ECQ34669466-B8967CF7-15D9-42F3-AA77-FEF416242D9AQ34798439-A5045AAA-481C-4511-9376-8AB5F08F4161Q34801672-2DD75C20-9A43-4A28-BA61-698A68E22D80Q34858484-3D04E1CA-9C8F-4111-B91C-235E8F280CCFQ34958488-E139CEA4-A7B2-44EF-8085-0E1FACF35E02Q35104007-51AE4507-A226-46BA-88FA-52172542F19AQ35152903-D121F8D4-92AD-4E36-AE35-E23C65A74436Q35216220-CC6614DC-686C-466F-B89D-4389AF091599Q35242303-D0D8837C-3B16-4765-9CA5-E4CC7FAC8B77Q35663610-71EB8B5C-02AC-4F2B-A3CF-B2BDF39BA77D
P2860
Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Control of mucin-type O-glycos ...... GalNAc-transferase gene family
@ast
Control of mucin-type O-glycos ...... GalNAc-transferase gene family
@en
Control of mucin-type O-glycos ...... GalNAc-transferase gene family
@nl
type
label
Control of mucin-type O-glycos ...... GalNAc-transferase gene family
@ast
Control of mucin-type O-glycos ...... GalNAc-transferase gene family
@en
Control of mucin-type O-glycos ...... GalNAc-transferase gene family
@nl
prefLabel
Control of mucin-type O-glycos ...... GalNAc-transferase gene family
@ast
Control of mucin-type O-glycos ...... GalNAc-transferase gene family
@en
Control of mucin-type O-glycos ...... GalNAc-transferase gene family
@nl
P2093
P2860
P3181
P356
P1433
P1476
Control of mucin-type O-glycos ...... GalNAc-transferase gene family
@en
P2093
E. P. Bennett
H. Clausen
L. A. Tabak
T. A. Fritz
T. A. Gerken
P2860
P304
P3181
P356
10.1093/GLYCOB/CWR182
P407
P577
2012-06-01T00:00:00Z